GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **201 - 225** of **4050** in total

« First

‹ Prev

…

5

6

7

8

9

10

11

12

13

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G00065MO	49
IgG	Patient 3	11	mild	G00065MO	44
IgM	Patient 3	-180	mild	G00065MO	109
IgA	Patient 3	4	mild	G00065MO	409
IgG	Patient 3	4	mild	G00065MO	46
IgM	Patient 3	11	mild	G00065MO	151
IgM	Patient 3	4	mild	G00065MO	170
IgA	Patient 4	12	mild	G00065MO	420
IgG	Patient 4	12	mild	G00065MO	72
IgM	Patient 4	12	mild	G00065MO	147
IgA	Patient 1	10	moderate	G00066MO	348
IgA	Patient 1	22	moderate	G00066MO	322
IgA	Patient 1	6	moderate	G00066MO	325
IgG	Patient 1	10	moderate	G00066MO	189
IgG	Patient 1	22	moderate	G00066MO	212
IgG	Patient 1	6	moderate	G00066MO	163
IgM	Patient 1	10	moderate	G00066MO	37
IgM	Patient 1	22	moderate	G00066MO	38
IgM	Patient 1	6	moderate	G00066MO	34
IgA	Patient 2	15	mild	G00066MO	1035
IgA	Patient 2	24	mild	G00066MO	1190
IgG	Patient 2	15	mild	G00066MO	185
IgG	Patient 2	24	mild	G00066MO	210
IgM	Patient 2	15	mild	G00066MO	2083
IgM	Patient 2	24	mild	G00066MO	2600